Position history for Wealthspire Advisors, LLC's holdings in Catalyst Pharmaceuticals, Inc.
Wealthspire Advisors, LLC holds 37,160 shares of CPRX (Catalyst Pharmaceuticals, Inc.), worth $867,315 as of 2025-Q4. The position was increased (++0.9% shares). CPRX represents 0.0% of Wealthspire Advisors, LLC's portfolio.
Current Value
$867,315
Current Shares
37,160
Total Value Change
+$288,820
Total Shares Change
+868
Other major holders of CPRX: BNP PARIBAS FINANCIAL MARKETS, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 37,160 |
+0.9% |
| $867,315 |
| 0.0% |
| $23.29 |
25 |
| 2025-Q3 | Decreased | 36,843 | -0.1% | $725,807 | 0.0% | $19.55 | 0 |
| 2025-Q2 | Increased | 36,879 | +7.1% | $800,275 | 0.0% | $21.78 | 27 |
| 2025-Q1 | Increased | 34,434 | +0.2% | $835,025 | 0.0% | $24.69 | 25 |
| 2024-Q4 | Increased | 34,355 | +0.3% | $716,989 | 0.0% | $21.07 | 25 |
| 2024-Q3 | Decreased | 34,271 | -5.6% | $681,308 | 0.0% | $19.56 | 0 |
| 2024-Q2 | Unchanged | 36,292 | 0.0% | $562,164 | 0.0% | $15.49 | 0 |
| 2024-Q1 | Unchanged | 36,292 | 0.0% | $578,495 | 0.0% | $15.94 | 0 |